ProfileGDS2971 / 7.1.4.10
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 25% 25% 23% 30% 12% 79% 64% 42% 63% 39% 61% 43% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.3499325
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.3291525
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.37953823
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.30649430
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)-0.79763812
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.45766779
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.2295664
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.11704142
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.23005463
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.12971139
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.19124761
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.035734243